-
Tentative US approval for Merck’s diabetes therapy
pharmatimes
July 24, 2017
The US Food and Drug Administration has given a tentative green light to Merck & Co’s follow-on biologic basal insulin Lusduna Nexvue.
-
Abbott Diabetes Care teams up with Bigfoot Biomedical to develop methods for diabetes management
biospectrumasia
July 20, 2017
The next generation of Abott’s FreeStyle Libre glucose sensing technology will be given to Bigfoot so it can use...
-
J&J’s type 2 diabetes drug INVOKANA significantly reduces major heart complications in CANVAS progra
biospectrumasia
June 28, 2017
These data from the integrated analysis of the CANVAS and CANVAS-R trials were published in the New England Journal of Medicine, and presented in a special symposium at the American Diabetes Association 77th Scientific Sessions.
-
Lilly Diabetes Brings an Extra Splash of Summertime Fun and Inspiration to Diabetes Camps with Launc
lilly
June 28, 2017
This U.S. diabetes camp support program has provided speakers, scholarships, medicines and educational materials since 2001
-
New LEADER Analysis Shows Victoza(R) Reduces Cardiovascular Risk in People With Type 2 Diabetes Rega
en-cphi.cn
June 14, 2017
Findings from a post hoc analysis of the LEADER cardiovascular (CV) outcomes trial showed that treatment with Victoza® (liraglutide) resulted in similar reductions in the risk of major cardiovascular events in people with type 2 diabetes at high CV risk.
-
Type 2 diabetes directly linked to BMI
pharmafile
June 13, 2017
This article introduces two types of diabetes directly linked to BMI
-
Top 10 diabetes drugs by 2016 sales
fiercepharma
June 13, 2017
To say there’s a lot going on in the U.S. diabetes space right now would be an understatement.
-
Sanofi’s insulin lispro receives CHMP positive opinion to treat diabetes
pharmaceutical-technology
May 27, 2017
The European Medicines Agency's (EMA's) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for the marketing authorisation of Sanofi's insulin lispro.
-
Merck's Glucophage® SR Receives Label Extension for Patients at High Risk of Type 2 Diabetes in the
en-cphi.cn
May 18, 2017
Merck, a leading science and technology company, today announced that the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK has authorized Glucophage® SR (sustained release formulation; metformin)...
-
Actress Angela Bassett joins For Your SweetHeart™ to urge people with diabetes to know their heart d
lilly
May 17, 2017
Bassett encourages people with type 2 diabetes and their loved ones to take and share the Heart You Quiz to learn more about the No. 1 killer of people with this condition